MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Altimmune EBITDA per Share 2011-2026 | ALT
Annual EBITDA per Share Altimmune
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.45 | -1.79 | -1.86 | -2.33 | -1.65 | -1.53 | -6.28 | -37.5 | -51.1 | -3.35 | -52.4 | -63.1 | -37 | -71.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.45 | -71.4 | -23.8 |
Quarterly EBITDA per Share Altimmune
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -0.29 | - | - | - | -0.38 | - | - | - | -0.44 | - | -0.5 | -0.43 | -0.44 | - | -0.79 | -0.6 | -0.38 | - | -0.55 | -1.02 | -0.48 | - | -0.75 | -0.26 | -0.24 | - | -2.96 | -5.6 | -8.82 | - | -59.7 | -0.32 | -0.65 | -0.8 | -0.07 | -0.02 | -0.02 | -0.01 | -0.03 | -0.03 | 0.02 | -0.04 | -0.07 | -0.02 | -0.04 | -0.1 | -0.06 | -0.03 | -0.02 | -0.03 | -0.04 | -0.03 | -0.03 | -0.02 | -0.06 | -0.06 | -0.1 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.02 | -59.7 | -1.94 |
EBITDA per Share of other stocks in the Biotechnology industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M |  Germany |
 |
I-Mab
IMAB
|
0.08 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B |  USA |
 |
Apellis Pharmaceuticals
APLS
|
0.45 | $ 20.24 | -2.22 % | $ 2.55 B | USA |
 |
Aptorum Group Limited
APM
|
0.34 | $ 0.82 | -2.95 % | $ 4.47 M | China |
 |
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M |  France |
 |
Axsome Therapeutics
AXSM
|
-3.34 | $ 165.96 | -0.25 % | $ 8.26 B | USA |
 |
AbCellera Biologics
ABCL
|
-0.67 | $ 3.74 | -2.23 % | $ 1.12 B |  Canada |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Burford Capital Limited
BUR
|
1.11 | $ 8.49 | -2.75 % | $ 1.38 B | Britain |
 |
Codexis
CDXS
|
-0.73 | $ 0.97 | -4.87 % | $ 71.2 M | USA |
 |
Adverum Biotechnologies
ADVM
|
-6.85 | - | - | $ 86.2 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
2.11 | $ 24.04 | 0.67 % | $ 2.94 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - |  Russia |
 |
Corvus Pharmaceuticals
CRVS
|
-0.48 | $ 17.32 | -3.19 % | $ 832 M | USA |
 |
Champions Oncology
CSBR
|
0.45 | $ 5.96 | -1.81 % | $ 81.4 M | USA |
 |
Daré Bioscience
DARE
|
-2.75 | $ 1.58 | -1.87 % | $ 13.4 M | USA |
 |
DBV Technologies S.A.
DBVT
|
-1.17 | $ 21.89 | -5.85 % | $ 2.12 B | France |
 |
ARCA biopharma
ABIO
|
-5.25 | - | 1052.0 % | $ 415 M | USA |
 |
Acer Therapeutics
ACER
|
-1.56 | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-1.72 | - | - | $ 2.17 B | USA |
 |
Acorda Therapeutics
ACOR
|
-188 | - | -24.86 % | $ 820 K | USA |
 |
Capricor Therapeutics
CAPR
|
-0.86 | $ 25.75 | -4.13 % | $ 690 M | USA |
 |
Eton Pharmaceuticals
ETON
|
-0.01 | $ 17.52 | -3.47 % | $ 449 M | USA |
 |
Exelixis
EXEL
|
3.32 | $ 40.72 | -0.76 % | $ 11.1 B | USA |
 |
Acasti Pharma
ACST
|
-1.38 | - | 4.01 % | $ 150 M | Canada |
 |
Amicus Therapeutics
FOLD
|
0.13 | $ 14.35 | -0.1 % | $ 4.43 B | USA |
 |
Galectin Therapeutics
GALT
|
-0.52 | $ 2.9 | -5.23 % | $ 181 M | USA |
 |
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | Germany |
 |
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | Canada |
 |
Galapagos NV
GLPG
|
-2.53 | $ 32.94 | -3.37 % | $ 2.69 B |  Belgium |
 |
Greenwich LifeSciences
GLSI
|
-1.23 | $ 27.32 | -0.27 % | $ 356 M | USA |
|
Galecto
GLTO
|
-1.49 | $ 29.84 | -0.7 % | $ 793 M |  Danmark |
 |
Genmab A/S
GMAB
|
10.4 | $ 27.53 | -7.17 % | $ 17.6 B | Danmark |
 |
Gossamer Bio
GOSS
|
-1.19 | $ 0.46 | 8.47 % | $ 70.2 M | USA |
 |
GeoVax Labs
GOVX
|
-14.7 | $ 1.53 | -1.92 % | $ 2.78 M | USA |
 |
Grifols, S.A.
GRFS
|
0.87 | $ 8.54 | -6.11 % | $ 6.83 B |  Spain |
 |
AgeX Therapeutics
AGE
|
-9.04 K | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | USA |
 |
Halozyme Therapeutics
HALO
|
4.01 | $ 69.01 | -1.2 % | $ 8.27 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-1.85 | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
-408 | $ 3.17 | -5.09 % | $ 1.13 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-2.42 | - | - | $ 7.46 M |  Israel |
 |
Hoth Therapeutics
HOTH
|
-1.29 | $ 0.99 | -2.47 % | $ 6.31 M | USA |
 |
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | USA |
 |
Agios Pharmaceuticals
AGIO
|
-8.05 | $ 28.49 | -2.57 % | $ 1.65 B | USA |
 |
Harmony Biosciences Holdings
HRMY
|
4.04 | $ 28.56 | -1.18 % | $ 1.64 B | USA |
 |
Advaxis
ADXS
|
-5.96 | - | -9.65 % | $ 45.9 M | USA |